Mobileye Global heads into its October 22 earnings with a fresh analyst downgrade, short interest at an 18-month high, and a stock that has lost nearly 12% over the past month, making it one of the more pressured setups in the autonomous driving space right now.
The most immediate catalyst is the Barclays action filed this morning. Dan Levy downgraded the stock from Overweight to Equal-Weight and cut his price target from $14 to $9, a move that lands squarely on the current price and effectively removes the firm's bullish stance. That downgrade matters because Barclays is also on the 13G register as a passive 5%-plus holder, so the firm is cutting a name it owns in size. The broader Street remains cautious: the consensus is a Hold, with 11 analysts at that rating against just four at Outperform. Most of the July earnings reaction was a wave of target reductions from JPMorgan, UBS, Mizuho, and RBC, all of which kept neutral-leaning ratings but pulled numbers lower. The mean target is now $11.48 against a price of $7.57, but that gap reflects lingering stale optimism more than genuine upside conviction given how quickly the targets have compressed over the past two months.
Short interest has been rebuilding in a hurry, and that is the positioning story this week. Shorts now hold 18.6% of the free float, up roughly 8% on the week and 17% over the past month, a clear acceleration that coincides with the stock making new lows. The FINRA fortnightly print puts short shares at just over 40 million, with days-to-cover at 11.5, meaning unwinding this position is not trivial. The ORTEX short score is 63, and while it has eased off the 68-plus readings seen earlier in September, it remains in firmly bearish territory. Cost to borrow jumped sharply to 0.58% on Tuesday from 0.05% the prior session, though the absolute level remains low, suggesting the surge is more likely a data artefact or same-day squeeze than a structural tightening. Availability is actually loosening: at 537% of short interest, there are more than five shares available to borrow for every one currently shorted, the most available the lending market has been since late August, which means the infrastructure for further short-building is well in place. Options positioning is essentially neutral: the put/call ratio at 0.50 is just fractionally below its 20-day average of 0.51, with a z-score close to zero, so no particular directional lean is coming through the options market.
The bull and bear cases are not subtle. Bulls point to Mobileye's position as the incumbent in advanced driver-assistance systems, a strong R&D pipeline, and a 90-day EPS momentum factor score at the 98th percentile, meaning analysts have been revising forward estimates sharply higher even as the stock has fallen. That divergence between earnings expectation and price is one of the more striking data points in the snapshot: the 12-month forward EPS momentum ranks in the 75th percentile. Bears counter that the company faces intensifying competition in ADAS and autonomous driving, has heavy exposure to a single parent-company relationship with Intel (which holds a 79.8% stake per its last 13G filing from November 2025), and delivered a post-earnings decline of 8.3% on the day and 10% over the five sessions following July results. Valuation gives the bears some comfort: the price-to-book has compressed to 0.76 and has fallen roughly 11% over the past 30 days, while EV/EBITDA sits at 8.7x, both reflecting a market that is marking the stock down rather than re-rating it higher.
The ownership picture has one genuinely notable feature. CEO Amnon Shashua filed a Schedule 13D in February 2026, establishing activist status at a 7.3% stake of approximately 17.8 million shares. A 13D from the company's own chief executive is unusual and signals a degree of conviction that runs counter to the short positioning. Shashua also received a further 1.6 million share award in July. Two independent directors, Safroadu Yeboah-Amankwah and Frank Yeary, made open-market purchases in August and July respectively, each spending roughly $100,000 at prices in the $7.98 to $8.46 range, close to current levels. These were discretionary purchases, not plan-driven grants, which gives them more signal weight. The net insider position over the past 90 days is a modest positive on open-market terms, though the much larger grant activity distorts the headline figure.
Wikipedia attention for MBLY is running at a z-score of 1.8 relative to its own 90-day history, a meaningful spike in retail attention that often coincides with price volatility rather than directional conviction.
With earnings 22 days away and the stock pressing against multi-year lows, the October 22 print becomes the next hard test: whether Mobileye can show that the EPS estimate revisions have a real-world foundation, and whether Barclays' downgrade this morning marks a reset of expectations or the start of another leg lower.
See the live data behind this article on ORTEX.
Open MBLY on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
